Directory profiles that have not opted in. Name, email, and a private contact are not listed. 52 states. Last updated 2026-10-16. Counts are on the catalog.
Page 800. The contact email is not on this page.
- MOLECULAR INTELLIGENCE LLC
NIH R43: Modeling Receptor-ligand interactions for Drug Discoveryfrom Cryo-EM data using AI
startup · IN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SNJ PHARMA INC.
NIH R43: Novel Plasmin-independent Thrombolytic Agent for Pulmonary Embolism
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MEDULATE LLC
NIH R43: Optimizing Central Venous Catheterization Training with Affordable Platform Technology
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MECHANOBIOLOGIX, LLC
NIH R43: Stiffness measurements in human lung slices to evaluate therapeutic and preventive potentials of anti-fibrotic drugs
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- HEALTH TEQUITY LLC
NIH R43: ACTIVATE: An AI-Enabled Multilingual Platform for Connected and Accessible Care Coordination and Remote Monitoring.
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NANOSCOPE INSTRUMENTS, INC.
NIH R44: Development of Multi-Luminance Shape Discrimination Test for Assessment of Functional Vision
startup · TX · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- TISSUERATE INC.
NIH R44: A novel bioactive bone graft to promote accelerated bone regeneration
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PURE GREEN PHARMACEUTICALS INC.
Form D history: Pharmaceuticals
startup · MI · amount not stated · 2022-11-22
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2022-11-22.
- NEOSPLICE THERAPEUTICS, INC.
NIH R43: Isoform?Resolved Target Discovery and Validation in Cancer
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- RESTOREAR DEVICES, LLC
NIH R44: Non-Invasive System to Deliver Therapeutic Hypothermia for Protection Against Noise-Induced Hearing Loss
startup · MT · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- TURING MEDICAL TECHNOLOGIES INC
NIH R44: Real-time head motion monitoring for all clinical MR sequences using Universal FIRMM
startup · MO · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- BIACURE THERAPIES, INC.
NIH R44: Using Targeted, Controlled High Frequency Energy for Treatment of Onychomycosis
startup · WI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- SOUND INNOVATION LLC
NIH R43: SoundScape: A portable small animal imager to accelerate drug development
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- Ventrix
Ventrix supports high-growth teams across revenue, product, and operations leadership by pairing founder-trusted search partners with startup-ready market insight. Ventrix helps protect runway by prioritizing the right executive hires.
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NEURONEXUS TECHNOLOGIES
NIH R43: Advanced culture and recording system for long-term electrophysiological profiling in human brain organoids
startup · MI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NeuroTherapia
NeuroTherapia is a clinical stage company developing new treatments for neuroinflammatory disorders, focusing on small molecule therapies to treat central nervous system diseases. Their lead product, NTRX-07, is a cannabinoid type 2 receptor agonist that targets neuroinflammation
startup · OH · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- INGENIOUS TARGETING LABORATORY, INC.
NIH R44: Research and Development to Establish a Small Animal Model as a Significant Resource of High-Value Single-Domain Antibodies
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PHOTOTHERMAL SPECTROSCOPY CORP.
NIH R44: High-Speed Automated Analysis of Sub-20 µm Microplastics by Photothermal Infrared Spectroscopy
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- OPTICARA LLC
NIH R44: Perfusion assessment of parathyroid glands intra-operatively using a hand heldlaser speckle contrast imaging
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- LONGIEVA THERAPEUTICS
NIH R43: Development of cannabinoid receptor 2 agonists for opioid use disorder
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PREVEP, INC.
NIH R43: Treatment of status epilepticus and refractory status epilepticus with intravenous topiramate.
startup · MD · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- UV01 TECHNOLOGIES, INC
NIH R43: Leveraging AI/ML for Environmental Health Risk Assessment in Homes
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VECGEN, INC
NIH R42: Pre-Market Approval (PMA) Enabling Validation of a Diagnostic to Predict Immune Responses to AAV-based Therapies for GNE Myopathy and Broad Ranging Indications
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MAGNIFY BIOSCIENCES INC.
NIH R43: Multiplex Magnify Protocol and Kit for High Plex, Superresolution 3D Synaptic Imaging and Analysis in Neuroscience
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- X-Therma Inc.
Form D history: Biotechnology
startup · CA · amount not stated · 2024-03-08
Directory profile (not opted in). scraped, medium. Source: SEC EDGAR. Updated 2024-03-08.
- IN VIVO ANALYTICS, INC.
NIH R44: A modular bioluminescence imaging platform using a novel multi-aperture method
startup · NY · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- RIBOSCIENCE, LLC
NIH R41: Inhibitors of ENPP1 for the treatment of hepatocellular carcinoma
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- HASENTECH, INC.
NIH R41: Dendritic cell therapy for GvHD
startup · IL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- NIMBUS RESEARCH LABORATORY, LLC
NIH R43: AdvanceBox System with Networked, Monitored, and Mapped Rescue Supply Containers (Phase I)
startup · RI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- THRIVE NEUROMEDICAL, LLC
NIH R44: Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
startup · OH · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ANCHORCHEM LLC
NIH R41: AnchorChem LLC: Pioneering Solutions to Create a Stable Supply Chain of Cyanopeptides and Cyanotoxins to Address Global Health Threats
startup · MI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- FORAGR MEDICINES, INC
NIH R43: Progression of RNA-targeted small molecules to treat Alzheimer's disease
startup · NC · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- PLANS4CARE INC.
NIH R44: Activites4Care: A Digital Platform to Enhance Caregiver Well-being by Providing Customized Activities that Improve Quality of Life for People Living with Dementia
startup · RI · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- RUBATO, INC.
NIH R41: Novel AI-driven music-based intervention to reduce behavioral and psychological symptoms for people living with dementia
startup · CA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- AAVINUE INC
NIH R43: A novel non-viral gene therapy for Alzheimer's Disease
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ENIGMA BIOMEDICAL USA, INC
NIH R44: Clinical Evaluation of a Novel [18F] Positron Emission Tomography (PET) Tracer for Differential Diagnosis and Staging of 4R Tauopathies
startup · TN · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- INCUTA THERAPEUTICS LLC
NIH R43: Injectable Hydrogel Treatment for Hidradenitis Suppurativa
startup · PA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- ARPHION, LTD
NIH R41: Use of neural networks and deep learning to construct a miRNA classifier to differentiate with high accuracy and noninvasively oral squamous cell carcinoma from benign leukoplakia
startup · IL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- VENTURA LIFE SCIENCES, LLC
NIH R41: Identification of AAV capsids with superior skeletal muscle transduction capability using cross-species analysis model
startup · FL · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.
- MASSACHUSETTS NEURO TECHNOLOGY, INC.
NIH R41: Developing a virtual reality guided acupuncture imagery treatment for Chronic low back pain
startup · MA · amount not stated · 2024-01-01
Directory profile (not opted in). scraped, medium. Source: Source. Updated 2026-01-01.